Alpha Cubed Investments’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$12.1M Sell
69,931
-1,259
-2% -$229K 0.42% 52
2025
Q3
$13.6M Buy
71,190
+66,975
+1,589% +$11.9M 0.47% 46
2025
Q2
$757K Buy
+4,215
New +$732K 0.03% 138

Other funds holding DGX

Alpha Cubed Investments's DGX Position: Q4 2025 in Review

Alpha Cubed Investments reduced its Quest Diagnostics (DGX) stake by 1.8% in Q4 2025, selling an estimated $229K and leaving 69,931 shares worth $12.1M. The position accounts for 0.42% of the portfolio, ranked #52.

Alpha Cubed Investments first reported a position in DGX in Q2 2025 and has held it in 3 quarters since. The position peaked at $13.6M in Q3 2025. 1,050 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • Alpha Cubed Investments held 69,931 shares of Quest Diagnostics worth $12.1M as of Q4 2025.
  • Alpha Cubed Investments sold 1,259 Quest Diagnostics shares in Q4 2025, an estimated $229K.
  • Quest Diagnostics made up 0.42% of Alpha Cubed Investments's portfolio in Q4 2025, its #52 holding.
  • Alpha Cubed Investments first reported a position in Quest Diagnostics in Q2 2025 and has held it in 3 quarters since.
  • Alpha Cubed Investments's Quest Diagnostics position peaked at $13.6M in Q3 2025.
  • 1,050 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Alpha Cubed Investments's 13F filing for Q4 2025, filed 3 Feb 2026.